The purpose of this study was to identify, in the in vitro rat neostriatal slice preparation, an electrophysiological response corresponding to the activation of striatal neurons by cortical afferents, and to study the actions of a variety of putative neurotransmitters on modulating synaptic transmission at this synapse. Local stimulation of the neostriatal slice evokes a field potential composed of 2 prominent negativities. Experiments using calcium antagonists and tetrodotoxin indicate that the first negativity (Nl) reflects the direct activation of intrinsic neurons and axons, while the second negativity (N2) is synaptically mediated. The afferent fibers eliciting the second negativity have not previously been identified because of the mixing of afferents within the striatum. However, similar field potential responses are elicited by stimulation of the corpus callosum, in which the only striatal afferents are crossed corticostriatal fibers. Kynurenate, y-D-glutamylglycine, and piperidine dicarboxylate all reversibly reduced or abolished N2, suggesting that the transmitter generating the response is an excitatory amino acid. Together, these results strongly suggest that N2 reflects activation of striatal neurons by corticostriatal afferents. Three putative striatal neurotransmitters, dopamine, acetylcholine and adenosine, were studied with respect to their ability to modulate the corticostriatal response. Dopamine had minimal effects on the waveform of the field potential.
In contrast, carbachol or adenosine consistently reversibly reduced or eliminated N2. Atropine blocked carbachol's actions, while theophylline blocked adenosine's actions, indicating that the compounds were acting on muscarinic and adenosine receptors, respectively. To test whether these were primarily pre-or postsynaptic actions, we recorded the response to ionophoretically applied glutamate while simultaneously recording the synaptically evoked field potential from the same location. Kynurenate reduced both responses simultaneously, while carbachol or adenosine reduced only the synaptically mediated N2. From these results we propose that the terminals of corticostriatal afferents may possess muscarinic and adenosine receptors that function to inhibit transmitter release.
The mammalian neostriatum contains a variety of putative neurotransmitters, including the highest concentrations of acetylcholine and dopamine found among any structures in the mammalian forebrain (Graybiel and Ragsdale, 1983) . It thus has been the subject of much research aimed at elucidating its biochemical anatomy. Electrophysiological analysis has proven more difficult, primarily because of its nonlaminar organization and the limitations inherent in utilizing in vivo preparations. Recently, however, several investigators have begun examining the electrophysiological properties of striatal neurons using the in vitro striatal slice preparation (Misgeld et al., 1979; Kita et al., 1985; Cordingley and Weight, 1986) . The purpose of this study was to identify, in the slice preparation, the electrophysiological response generated by the cortical input to the neostriatum and to examine the actions of compounds that may presynaptically inhibit this input. The entire cerebral cortex projects topographically to the neostriaturn and thereby provides a major afferent input (Kemp and Powell, 197 1) . Presynaptic modulation of the corticostriatal pathway would have profound consequences for the transfer of information from cortex to striatum and for the functioning of the extrapyramidal, as well as other behaviorally relevant, systems. Yamamoto (1973) first reported that local stimulation in the striatal slice evokes a field potential consisting of 2 negative waves. It has been suggested that the first component represents the direct and antidromic activation of axons and intrinsic neurons, while the second component appears to be synaptically mediated (Takagi and Yamamoto, 1978; Misgeld et al., 1979; Cordingley and Weight, 1986) . The identity of the neurotransmitter responsible for generating the second negativity is unclear. Misgeld and his colleagues (1980) have reported that nicotinic antagonists block this component, and therefore concluded that it is mediated by ACh released from intrinsic cholinergic neurons and acting on nicotinic receptors. On the other hand, Cordingley and Weight (1986) have found that nicotinic antagonists have no effect on the field potential's second component and instead have proposed that it is mediated by a glutamatelike transmitter. In the initial part of this study, we examine the actions of both nicotinic antagonists and excitatory amino acid antagonists on the field potential evoked by local stimulation in the in vitro rat neostriatal slice preparation. In addition, by carefully positioning stimulating and recording microelectrodes, we attempt to unequivocally identify a corticostriatal response.
Several compounds may have significant actions on the cortical input to the neostriatum, specifically, dopamine (DA), carbachol, and adenosine. are found on the terminals of the cortical afferents to the striatum (Schwartz et al., 1978; Komhuber and Komhuber, 1986) and that DA can inhibit the release of glutamate from striatal slices (Mitchell and Doggett, 1980; Rowlands and Roberts, 1980) . Muscarinic agonists, such as carbachol, have been reported to decrease the second negativity of the field potential, perhaps by acting at a presynaptic locus (Takagi and Yamamoto, 1978; Weiler et al., 1984) . Finally, adenosine and its receptors are found in reasonably high concentrations in the striatum (Goodman and Snyder, 1982) and in a variety of other systems have been shown to presynaptically inhibit excitatory synaptic transmission (Ginsborg and Hirst, 1972; Okada and Ozawa, 1980; Kocsis et al., 1984; Dunwiddie and Haas, 1985) . In the second part of this study, we examine the actions of DA, carbachol, and adenosine on the corticostriatal response.
Materials and Methods
Neostriatal slices were prepared from female, Wistar rats (180-240 gm) using standard techniques. The animals were deeply anesthetized with sodium pentobarbital(60 mg/kg, i.p.) and decapitated. The dorsal surface of the brain was immediately exposed, and a 4-6 mm coronal section of one hemisphere was removed by hemisecting the brain and then making coronal cuts approximately 3 and 7-9 mm from the tip of the frontal poles. This tissue block was immediately immersed in cold (2+C), modified Krebs solution and then glued to the stage of a Vibratome with cyanoacrylate. Coronal slices, 400 pm thick, were then cut, and included neocortex, corpus callosum, and neostriatum. Slices were stored in oxygenated modified Krebs solution at room temperature and were allowed to stabilize for at least 1 hr before being transferred to the recording chamber. A single slice was transported to the recording chamber (volume, 1.0 cm'), where it was held between 2 nylon nets, submerged beneath continuously flowing (3-5 cm'/min) modified Krebs solution consisting of (in mM) NaCl, 124; KCl, 3.0; MgCl,, 2.0; CaCl,, 2.0; NaHCO,, 26.0; NaH,PO,, 1.3; dextrose, 10.0. The solution was saturated with 95% 0, and 5% CO, (pH 7.4). All drugs were obtained from Sigma and were made up at high concentrations (lo-100 mM) in distilled water and diluted to their final concentrations in the bathing medium immediately before application.
Standard field potential recording techniques were used. Electrodes (2-8 MO) were pulled from "omega dot" glass capillary tubing (2.0 mm O.D., 1.0 mm I.D.) and filled with 3 M NaCl. Signals were amplified using an Axon Instruments Axoprobe-1 and then digitized with a Nicolet 1170 signal averager and stored on magnetic tape. Slices were stimulated by constant-current cathodal pulses (40 psec duration) delivered through monopolar tungsten electrodes. The stimulating and recording microelectrodes were positioned approximately 0.5-3.0 mm Figure 1 . N2 is synaptically mediated and is blocked by kynurenate. A-C, Application for 3 min of a solution containing 0.5 mM CaCl, and 6.0 mM MgCl, reversibly blocked N2 without affecting Nl. C-E, Kynurenate (1 mM) also re@Mm versibly blocked N2 within 2 min of application. F, TTX (0.3 PM) blocked both Nl and N2. In this and all subsequent experiments, a stable control field potential was obtained and drugs were then sequentially applied to the same slice. apart, with the stimulating microelectrode placed either directly in the corpus callosum or immediately (within 500 pm) ventral to it and the recording microelectrode placed ventral to the stimulating electrode. Sodium glutamate (1 .O M, pH 8) was applied ionophoretically by positioning the ionophoretic microelectrode as close as possible to the recording microelectrode under visual control and then moving it through the depth of the slice to obtain a maximal response. At the conclusion of each experiment involving glutamate ionophoresis, the ionophoretic microelectrode was raised out of the slice so that its tip was in the bathing medium and the electrical response to glutamate application was then recorded. The coupling artifact thus recorded was digitally subtracted from the previously recorded glutamate responses.
Results
The field potential elicited by intrastriatal stimulation consists of 2 negativities (Nl and N2; Fig. 1A ) (Yamamoto, 1973; Misgeld et al., 1979; Cordingley and Weight, 1986) . Nl is thought to reflect direct activation of neuronal elements, while N2 is synaptically mediated (Takagi and Yamamoto, 1978; Misgeld et al., 1979; Cordingley and Weight, 1986) . However, there is some question about the transmitter and pathway mediating N2 (Takagi and Yamamoto, 1978; Misgeld et al., 1980; Cordingley and Weight, 1986) . Figure 1 , A-C, shows that N2 is reversibly blocked by a low-calcium (0.5 mM), high-magnesium (6.0 mM) solution, while Nl is unaffected (n = 5). The nicotinic antagonists mecamylamine (100 PM; n = 3) and d-tubocurarine (30 PM; n = 4) had no effect on either component of the field potential, even when applied for up to 30 min. In contrast, kynurenate (1 mM), an excitatory amino acid antagonist (Ganong et al., 1983; Jahr and Yoshioka, 1986) reversibly blocked or reduced N2 within 2 min of bath application without affecting Nl (n = 21; Fig. 1 , C-E). Both Nl and N2 were blocked by TTX (n = 3; Fig. lF ), indicating that they are both dependent on sodium-mediated spike discharges.
As would be expected, Nl was virtually unaffected by any dose of kynurenate at any stimulation strength ( Fig. 2A) . The antagonistic action of kynurenate on N2 was dose-dependent and observed at all stimulation strengths (Fig. 2B) . To further test whether N2 is mediated by an excitatory amino acid, the effects of 2 other excitatory amino acid antagonists were examined. Both y-o-glutamylglycine (1 mM; n = 3) and piperidine dicarboxylate (1 mM; y1 = 3; Fig. 6P') reversibly reduced or blocked N2 without affecting Nl. ascorbate; Fig. 31 had no consistent or significant effects on either Nl or N2. This lack of effect of DA on N2 is consistent with the results of 2 recent studies, which call into question the existence of DA receptors on the terminals of corticostriatal afferents (Trugman et al., 1986; Joyce and Marshall, 1987) .
In contrast to DA, muscarinic agonists have been reported to significantly reduce N2 and intracellularly recorded EPSPs (Takagi and Yamamoto, 1978; Misgeld et al., 1982; Weiler et al., 1984) . In agreement with these reports, we found that carbachol (5-20 ELM), a muscarinic agonist, reversibly reduced or blocked N2 (Figs. 4, 5 ; y1 = 13). Carbachol's action was prevented by the coapplication of atropine (l-3 PM) ( Fig. 4E ; n = 7), demonstrating that carbachol was indeed acting on muscarinic receptors in the striatum. Figure 4F also demonstrates that the same N2 component that was reduced by carbachol was also eliminated by kynurenate. Contrary to previous reports (Misgeld et al., 1982; Weiler et al., 1984) , application of atropine by itself did not increase the amplitude of N2 (Fig. 40) , even when the N2 amplitude was clearly submaximal.
To begin to test whether carbachol was exerting its actions pre-or postsynaptically, the response to ionophoretically applied glutamate was recorded while simultaneously recording the synaptically evoked field potential from the same location. If an agent is acting presynaptically and inhibiting transmitter release, then the ionophoretically induced glutamate field potential should be unaffected at a time when the synaptically mediated field is reduced. An agent acting postsynaptically would be expected to affect both field potentials to a similar degree (see Discussion for possible problems with this interpretation). Figure 5 shows that the ionophoretically induced glutamate Figure 2 . Kynurenate reduces N2 in a dose-dependent manner independent of stimulus intensity, while Nl is unaffected. The graphs show the amplitudes of Nl (A) and N2 (B) as a function of stimulation intensity from an experiment in which 4 different concentrations of kynurenate (0.2, 0.4, 0.8, and 1.6 mM) were applied successively to the same slice. Note that after the washout of 1.6 mM kynurenate, the N2 amplitude returned to its control values.
It is generally accepted that the major glutaminergic input to the neostriatum derives from cortical afferents (Dray, 1980; Graybiel and Ragsdale, 1983) . Therefore, it is likely, as suggested previously (Cordingley and Weight, 1986) , that N2 is due to the activation of cortical afferents and the subsequent release of glutamate. Consistent with this hypothesis was our finding that we could elicit a kynurenate-sensitive N2 component with the stimulating microelectrode placed directly in the corpus callosum.
DA has been reported to decrease the release of glutamate from neostriatal slices (Mitchell and Doggett, 1980; Rowlands and Roberts, 1980) and receptor binding studies have suggested that the terminals of neocortical afferents possess DA receptors (Schwartz et al., 1978) . However, we found that bath application of DA [l-100 PM with (n = 8) or without (n = 7) 0.3 mM field potential is unaffected by carbachol at a time when the stimulus-evoked N2 component is significantly reduced. Kynurenate, unlike carbachol, reduced both field potentials simultaneously with a similar time course, demonstrating that the field potential recorded in response to ionophoretic application of glutamate was indeed due to the activation of functional glutamate receptors. These results are consistent with the hypothesis that muscarinic receptors localized on the terminals of corticostriatal afferents can inhibit transmitter release.
Adenosine has been found to presynaptically inhibit excitatory synaptic transmission in a variety of brain regions (Okada and Ozawa, 1980; Kocsis et al., 1984; Dunwiddie and Haas, 1985) . Both in situ radioligand binding studies (Goodman and Snyder, 1982) and electrophysiological studies (Kostopoulos and Phillis, 1977; Trussell and Jackson, 1985) suggest that there are moderately high concentrations of adenosine receptors in the neostriatum. Furthermore, adenosine antagonists have locomotor stimulatory effects, suggesting a role for adenosine in the control of motor activity (Daly et al., 198 1) . Therefore, we examined the actions of adenosine on N 1 and N2. Like kynurenate and carbachol, adenosine (0.1-0.5 mM) reversibly decreased or abolished N2 without significantly affecting Nl (Fig. 6 , A-C, n = 8). Application of theophylline (0.1-0.3 mM), a well-established adenosine antagonist (Daly et al., 1981) blocked the reduction of N2 by adenosine ( Fig. 6E ; n = 3), demonstrating that this action is mediated by adenosine receptors.
To determine whether adenosine was acting primarily pre-or postsynaptically to reduce N2, we again utilized the procedure of recording simultaneously the synaptically evoked N2 and the field response to ionophoretically applied glutamate. Figure 7B shows that at a time when adenosine had significantly reduced N2, the glutamate field potential was unaltered (n = 3). In contrast, kynurenate reduced both field potentials simultaneously (Fig. 70) . Thus, like carbachol, adenosine likely reduces or blocks N2 by acting presynaptically to inhibit transmitter release. A-C, Application of carbachol(l0 PM) reversibly reduced N2 without affecting Nl. D, E, Subsequent application of atropine (2 PM) had no effect on the field by itself, but blocked the action of carbachol. F, After washout ofcarbachol and atropine, kynurenate (1 mM) blocked N2.
Discussion
The corticostriatal projection comprises the major input to the neostriatum using glutamate as the neurotransmitter (Dray, 1980; Graybiel and Ragsdale, 1983) . In agreement with previous suggestions (Takagi and Yamamoto, 1978; Cordingley and Weight, 1986) we have presented evidence that the second negativity (N2) of the locally evoked field potential in neostriatal slices corresponds primarily to the synaptic activation of striatal neurons by cortical afferents. Thus, 3 different excitatory amino acid antagonists (kynurenate, piperidine dicarboxylate, and Y-Dglutamylglycine) reversibly reduce or block N2. Furthermore, direct stimulation of the corpus callosum also elicits a kynurenate-sensitive N2 component of the field potential.
Anatomical studies have demonstrated that the only neostriatal afferents that run through the corpus callosum come from neocortex (Carman et al., 1965; Carpenter and Sutin, 1983) . Thalamic afferents pass directly into the neostriatum (Powell and Cowan, 1956; Carpenter and Sutin, 1983 ) and would not be activated by callosal stimulation. There is no evidence to support the existence of intrinsic glutaminergic neurons or afferent sources of excitatory amino acids other than cerebral cortex and thalamus. Afferent or intrinsic pathways not utilizing excitatory amino acid transmitters are also likely stimulated when the cortical afferents are activated, but the virtual absolute blockade of N2 by kynurenate strongly suggests that N2 overwhelmingly reflects the synaptic responses of neostriatal neurons to the activation of cortical afferents. Misgeld and colleagues (1980) have previously presented evidence that nicotinic antagonists can reduce N2. However using the same nicotinic antagonists as Misgeld et al. (1980) , we found no effect on N2. We have no explanation for this discrepancy, except to note that neither Cordingley and Weight (1986) nor Takagi and Yamamoto (1978) found that nicotinic antagonists had any significant actions on N2. Muscarinic agonists have consistently been found to reduce N2 (Takagi and Yamamoto, 1978; Weiler et al., 1984) , as well as intracellularly recorded EPSPs (Dodt and Misgeld, 1986) but also have significant direct depolarizing actions on striatal neurons (Dodt and Misgeld, 1986) . Using the technique of simultaneously recording the synaptically evoked N2 and the field potential evoked by the ionophoretic application of glutamate, we found that while both responses were reduced by kynurenate, only N2 was affected by carbachol. We interpret this result as indicating that carbachol is acting presynaptically to inhibit corticostriatal synaptic transmission. Further support for this hypothesis comes from the observation that carbachol, at the doses used in this study, has no effect on either the membrane potential or input resistance of striatal neurons (Dodt and Misgeld, 1986) .
ACh, acting on muscarinic receptors, has been shown to inhibit synaptic transmission at synapses utilizing excitatory amino acids in a variety of systems, including rat ventral horn cells (Jiang and Dun, 1986) and hippocampus (Hounsgaard, 1978; Valentino and Dingledine, 198 1) . The presynaptic inhibitory action of ACh may be due to either a reduction in calcium conductance or to an increase in potassium conductance occurring at or near the axon terminal (North, 1986) .
The validity of our conclusion concerning the locus of car- bachol's action is dependent on the assumption that the same group of postsynaptic glutamate receptors is being activated by synaptically released transmitter and the exogenously applied glutamate. This seems likely, since both responses were recorded via the same recording electrode, but it is conceivable that the 2 responses reflect the activation of different populations of receptors, with different sensitivities to the postsynaptic actions of carbachol. The biochemical anatomy of the neostriatum has received a great deal of attention (Graybiel and Ragsdale, 1983) . One fairly well-developed classification, based primarily on staining for AChE, divides the neostriatum into striosomes and matrix. Striosomes are areas that stain poorly for AChE (Graybiel and Ragsdale, 1978) exhibit dense patches of opiate receptor binding (Herkenham and Pert, 198 l) , and are enriched in immunoreactivity for enkephalin and substance P (Graybiel et ai., 198 1) . The extrastriosomal matrix exhibits high AChE histochemical staining (Graybiel and Ragsdale, 1978) and high immunoreactivity to choline acetyltrasferase suggesting that the cholinergic neuropil is concentrated primarily in the matrix. In our experiments, carbachol always reduced N2 independent of microelectrode placement. This may reflect (1) the fact that the striosomal-matrix distinction becomes much less dramatic in adult animals (Graybiel and Ragsdale, 1983) , (2) the inability of our recording techniques to discern subtle spatial differences in the density of muscarinic receptors present in neostriatum, or (3) our selection criteria for "good" field potentials inadvertently results in the consistent placement of the recording electrode in the matrix.
Like carbachol, adenosine reduced or blocked N2 at a time when the glutamate field response was unaffected, suggesting that adenosine may also presynaptically inhibit synaptic transmission between cortical afferents and neostriatum. Adenosine has a similar action in the hippocampus, where it has been shown to inhibit the release of glutamate (Dolphin and Archer, 1983; Corradetti et al., 1984) and to presynaptically inhibit excitatory synaptic transmission (Okada and Ozawa, 1980; Dunwiddie and Haas, 1985) . Functional adenosine receptors are also found on the terminals of the cerebellar parallel fibers (Kocsis et al., 1984) . In cultured neostriatal cells, adenosine has been shown to increase membrane conductance to potassium (Trussell and Jackson, 1985) . If adenosine had the same action on presynaptic nerve terminals, it would be expected to decrease stimulus-evoked neurotransmitter release. However, adenosine may also have actions on the voltage-dependent calcium conductance at the terminal (Wakade and Wakade, 1978) or interfere intracellularly with the calcium-stimulated secretory process (Silinsky, 1984) .
All areas of the cerebral cortex project to the striatum topographically. However, the corticostriatal projection is not uniform, but derives, rather, from a number of distinct subclasses of cortical neurons with different axonal collaterals and projections (Jones et al., 1977; Wilson, 1987) . Furthermore, diverse cortical regions may project to the same striatal zones (Selemon and Goldman-Rakic, 1985; Malach and Graybiel, 1986) . The segregation of receptors for ACh or adenosine on distinct subsets of corticostriatal fibers would permit the selective inhibition of input to the striatum from diverse regions of cerebral cortex or from distinct classes of cortical neurons. Quantitative autoradiography of binding sites following selective cortical lesions will help determine whether all or a subset of corticostriatal fibers possess receptors for ACh or adenosine. and Kocsis * Presynaptic Inhibition of Corticostriatal Pathway
